Please provide your email address to receive an email when new articles are posted on . Black and Hispanic respondents with asthma exacerbations were less likely to seek acute care based on symptoms.

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in ...

Improvement across all asthma control parameters was achieved after 12 months of biologic treatment, according to one study. Patients with severe asthma treated with either omalizumab, benralizumab, ...

An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment ...

BOSTON -- Patients with severe, uncontrolled asthma had significantly higher odds of improvement in asthma-related sleep disturbances and improvement in activity levels when treated with tezepelumab ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...

Individuals with severe asthma have elevated concentrations of CSF neurogranin and amplification of synaptic degeneration associated with cardiovascular risk. Patients with severe asthma have ...